Detalhe da pesquisa
1.
Structural revision of the Mcl-1 inhibitor MIM1: synthesis and biological studies on ovarian cancer cells with evaluation of designed analogues.
Org Biomol Chem
; 19(41): 8968-8987, 2021 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34596646
2.
A Proteomic Study Suggests Stress Granules as New Potential Actors in Radiation-Induced Bystander Effects.
Int J Mol Sci
; 22(15)2021 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34360718
3.
Tumor Suppressive Role of miR-342-5p in Human Chondrosarcoma Cells and 3D Organoids.
Int J Mol Sci
; 22(11)2021 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34070455
4.
Calcium signals inhibition sensitizes ovarian carcinoma cells to anti-Bcl-xL strategies through Mcl-1 down-regulation.
Apoptosis
; 20(4): 535-50, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25627260
5.
Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice.
Blood
; 119(24): 5722-30, 2012 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22438253
6.
Development of optimized cytotoxicity assays for assessing the antitumor potential of CAR-T cells.
J Immunol Methods
; 525: 113603, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147898
7.
Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
Apoptosis
; 18(4): 492-508, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23344663
8.
In vitro genotoxicity potential investigation of 7 oxy-PAHs.
Environ Mol Mutagen
; 64(3): 176-186, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36757094
9.
MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells.
Front Oncol
; 13: 1220459, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37719019
10.
Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma.
J Exp Clin Cancer Res
; 42(1): 260, 2023 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37803448
11.
The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.
Mol Oncol
; 15(12): 3659-3678, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34160887
12.
Network-Based Integration of Multi-Omics Data Identifies the Determinants of miR-491-5p Effects.
Cancers (Basel)
; 13(16)2021 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439123
13.
Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.
Carcinogenesis
; 31(6): 984-93, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20142415
14.
Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis.
Int J Cancer
; 126(4): 885-95, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19634140
15.
Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib.
Cell Death Dis
; 11(5): 380, 2020 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424251
16.
Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids.
Mol Cancer Ther
; 19(7): 1506-1519, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32371581
17.
Bystander effectors of chondrosarcoma cells irradiated at different LET impair proliferation of chondrocytes.
J Cell Commun Signal
; 13(3): 343-356, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30903603
18.
Antitumor activity of nanoliposomes encapsulating the novobiocin analog 6BrCaQ in a triple-negative breast cancer model in mice.
Cancer Lett
; 432: 103-111, 2018 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29883750
19.
Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode.
Eur J Med Chem
; 159: 357-380, 2018 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30308410
20.
Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route.
Oncol Rep
; 38(4): 1949-1958, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28791387